SIRT1 and metabolic dysfunction-associated steatotic liver disease: SIRT1 has been shown to play a protective role against ALD and non-alcoholic fatty liver disease (NAFLD) by changing the acetylation status of target molecules to seemingly inhibit inflammation and steatosis.